ClinVar Miner

Submissions for variant NM_000090.3(COL3A1):c.3325C>T (p.Arg1109Ter) (rs112371422)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000618906 SCV000738519 pathogenic Cardiovascular phenotype 2017-04-17 criteria provided, single submitter clinical testing Lines of evidence used in support of classification: Alterations resulting in premature truncation (e.g.reading frame shift, nonsense)
Collagen Diagnostic Laboratory,University of Washington RCV000087665 SCV000120557 pathogenic Ehlers-Danlos syndrome, type 4 no assertion criteria provided clinical testing
Invitae RCV000087665 SCV000631659 pathogenic Ehlers-Danlos syndrome, type 4 2017-05-11 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal at codon 1109 (p.Arg1109*) of the COL3A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL3A1 are known to be pathogenic. This particular variant has been reported in the literature in an individual with Ehlers-Danlos syndrome IV (PMID: 24922459). ClinVar contains an entry for this variant (Variation ID: 101427). For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.